Genetic analyses of apparently sporadic pheochromocytomas: The Rotterdam experience

Annals of the New York Academy of Sciences

Volumn 1073, Issue , 2006, Pages 138-148

  Korpershoek, E ^a   Van Nederveen, F H ^a   Dannenberg, H ^a   Petri, B J ^a   Komminoth, P ^b   Perren, A ^b   Lenders, J W ^c   Verhofstad, A A ^c   De Herder, W W ^a   De Krijger, R R ^a   Dinjens, Winand N M ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Germline; Mutations; Pheochromocytoma; RET; SDHB; SDHD; Sporadic; VHL

Indexed keywords

PROTEIN RET; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE D; VON HIPPEL LINDAU PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; PHEOCHROMOCYTOMA;

EID: 33845477747     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1353.014     Document Type: Conference Paper

References (26)

1. LENDERS, J.W. et al. 2005. Phaeochromocytoma. Lancet 366: 665-675.
2. BRYANT, J. et al. 2003. Pheochromocytoma: the expanding genetic differential diagnosis. J. Natl. Cancer. Inst. 95: 1196-1204.
3. MAHER, E.R. & C. ENG. 2002. The pressure rises: update on the genetics of phaeochromocytoma. Hum. Mol. Genet. 11: 2347-2354.
4. ENG, C. 1996. Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N. Engl. J. Med. 335: 943-951.
5. NEUMANN, H.P. et al. 2002. How many pathways to pheochromocytoma? Semin. Nephrol. 22: 89-99.
6. PECZKOWSKA, M. & A. JANUSZEWICZ. 2005. Multiple endocrine neoplasia type 2. Fam. Cancer 4: 25-36.
7. THAKKER, R.V. 2001. Multiple endocrine neoplasia. Horm Res. 56(Suppl 1): 67-72.
8. GIMM, O. 2005. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx. Fam. Cancer 4: 17-23.
9. KIM, W.Y. & W.G. KAELIN. 2004. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22: 4991-5004.
10. BAYSAL, B.E. 2003. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol. Metab. 14: 453-459.
11. NEUMANN, H.P. et al. 2004. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292: 943-951.
12. MULLER, U., C. TROIDL & S. NIEMANN. 2005. SDHC mutations in hereditary paraganglioma/pheochromocytoma. Fam. Cancer 4: 9-12.
13. BAYSAL, B.E. et al. 2004. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J. Med. Genet. 41: 703-709.
14. BOURGERON, T. et al. 1995. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat. Genet. 11: 144-149.
15. GIMENEZ-ROQUEPLO, A.P. et al. 2003. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res. 63: 5615-5621.
16. VAN NEDERVEEN, F.H. et al. 2006. The occurrence of SDHB gene mutations in pheochromocytomas. Ann. N. Y. Acad. Sci. This Volume.
17. KOMMINOTH, P. et al. 1995. Molecular diagnosis of multiple endocrine neoplasia (MEN) in paraffin-embedded specimens. Endocr. Pathol. 6: 267-278.
18. VAN DER HARST, E. et al. 1998. Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas. Int. J. Cancer 79: 537-540.
19. DANNENBERG, H. et al. 2003. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas. Int. J. Cancer 105: 190-195.
20. VAN DER HARST, E. et al. 1998. Germline mutations in the VHL gene in patients presenting with phaeochromocytomas. Int. J. Cancer 77: 337-340.
21. DANNENBERG, H. et al. 2005. Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD. J. Clin. Oncol. 23: 1894-1901.
22. KOMMINOTH, P. et al. 1994. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am. J. Pathol. 145: 922-929.
23. BRAUCH, H. et al. 1991. Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the ret protooncogene. J. Clin. Endocrinol. Metab. 82: 4101-4104.
24. CASCON, A. et al. 2004. Genetic and epigenetic profile of sporadic pheochromocytomas. J. Med. Genet. 41: e30.
25. NEUMANN, H.P. et al. 2002. Germline mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346: 1459-1466.
26. TASCHNER, P.E. et al. 2001. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 31: 274-281.